Ferrari Slides 3.2% as Investors Weigh 2026 Margin and Delivery Concerns

Ferrari N.V. (RACE) is down 3.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be a mix of valuation pressure and investor caution around 2026 execution, rather than a fresh negative filing from the company. This could be because the stock has recently faced concern that heavy model launches may temporarily pressure shipments and margins even as the underlying business remains strong.

Details:

Ferrari’s latest quarterly update showed continued revenue, profit, and cash-flow growth, along with a higher 2026 outlook, which suggests today’s drop was probably not caused by a deterioration in the core business.

A recent SEC filing in mid-September was a routine foreign issuer report, not an obvious negative corporate event such as reduced guidance, a surprise capital raise, or a major governance issue.

A recent analyst target cut highlighted expectations for reduced shipments in coming quarters and some margin dilution tied to Ferrari’s product ramp, giving investors a concrete reason to trim positions.

Ferrari is also continuing a multi-year share repurchase program, which signals confidence from management, but buybacks do not always prevent short-term pullbacks when sentiment turns cautious.

Sources:

Ferrari, SEC, TipRanks

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$RACE Hedge Fund Activity

We have seen 325 institutional investors add shares of $RACE stock to their portfolio, and 457 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 2,410,068 shares (+inf%) to their portfolio in Q2 2026, for an estimated $897,244,215
VIKING GLOBAL INVESTORS LP added 2,204,309 shares (+inf%) to their portfolio in Q2 2026, for an estimated $820,642,197
GOLDMAN SACHS GROUP INC removed 578,753 shares (-37.1%) from their portfolio in Q2 2026, for an estimated $215,463,954
WCM INVESTMENT MANAGEMENT, LLC removed 424,528 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $143,681,501
ILEX CAPITAL PARTNERS (UK) LLP removed 405,842 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $151,090,918
CONTOUR ASSET MANAGEMENT LLC added 404,397 shares (+inf%) to their portfolio in Q2 2026, for an estimated $150,552,959
MORGAN STANLEY added 400,307 shares (+14.3%) to their portfolio in Q2 2026, for an estimated $149,030,293

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$RACE Congressional Stock Trading

Members of Congress have traded $RACE stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $RACE stock by members of Congress over the last 6 months:

SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$RACE Analyst Ratings

Wall Street analysts have issued reports on $RACE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Wolfe Research issued a "Outperform" rating on 07/07/2026

To track analyst ratings and price targets for $RACE, check out Quiver Quantitative's $RACE forecast page.

$RACE Price Targets

Multiple analysts have issued price targets for $RACE recently. We have seen 2 analysts offer price targets for $RACE in the last 6 months, with a median target of $467.5.

Here are some recent targets:

Zuzanna Pusz from UBS set a target price of $497.0 on 07/02/2026
Adam Jonas from Morgan Stanley set a target price of $438.0 on 06/15/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.